Xiaohu Xie

Dr. Xiaohu Xie

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
WXWenjin Xu
Wenjin Xu
QHQingxiao Hong
Qingxiao Hong
ZLZi Lin
Zi Lin
HMHong Ma
Hong Ma
WCWeisheng Chen
Weisheng Chen
HLHuifen Liu
Huifen Liu

1 September 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
XXXiaohu Xie
Xiaohu Xie
HLHuifen Liu
Huifen Liu
Jianbing ZhangJianbing Zhang
Jianbing Zhang
Wei-Sheng ChenWei-Sheng Chen
Wei-Sheng Chen
DZDingding Zhuang
Dingding Zhuang
WZWenhua Zhou
Wenhua Zhou

3 August 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
WXWenjin Xu
Wenjin Xu
MZMing Zhao
Ming Zhao
ZLZi Lin
Zi Lin
HLHaixiong Liu
Haixiong Liu
HMHong Ma
Hong Ma
HLHuifen Liu
Huifen Liu
Background: Drug addiction is an uncontrolled, chronic, and recurrent encephalopathy that presently lacks specific and characteristic biomarkers for diagnosis and treatment. As regulators of gene expression, microRNAs (miRNAs) are increasingly used for diagnostic and prognostic purposes in various disease states. Previous studies indicated that miRNAs play important roles in the development and progression of drug addictions, including addiction to methamphetamine, cocaine, alcohol, and heroin.Methods: We identified significant miRNAs using the microarray method and then validated the hsa‐miR‐181a expression levels in 53 heroin addiction patients and 49 normal controls using quantitative real‐time reverse transcription‐polymerase chain reaction (qRT‐PCR). Finally, the potential associations between transcriptional levels in heroin addiction patients and their clinicopathological features were analyzed.Results: A total of 2006 miRNAs were differentially expressed between heroin addiction patients and normal controls. The top 10 up‐regulated miRNAs in patients were hsa‐miR‐21a, hsa‐miR‐181a, hsa‐miR‐4459, hsa‐miR‐4430, hsa‐miR‐4306, hsa‐miR‐22‐3P, hsa‐miR‐486‐5P, hsa‐miR‐371b‐5P, hsa‐miR‐92a‐3P, and hsa‐miR‐5001‐5P. The top 10 down‐regulated miRNAs in patients were hsa‐miR‐3195, hsa‐miR‐4767, hsa‐miR‐3135b, hsa‐miR‐6087, hsa‐miR‐1181, hsa‐miR‐4785, hsa‐miR‐718, hsa‐miR‐3141, hsa‐miR‐652‐5P, and hsa‐miR‐6126. The expression level of hsa‐miR‐181a in heroin addiction patients was significantly increased compared with that in normal controls (P < .001). The area under the receiver operating characteristic curve of hsa‐miR‐181a was 0.783, the sensitivity was 0.867, and the specificity was 0.551.Conclusions: The increased expression of hsa‐miR‐181a in the plasma of heroin patients may be a consequence of the pathological process of heroin abuse. This study highlights the potential of hsa‐miR‐181a as a novel biomarker for the diagnosis of heroin addiction.

29 June 2021 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
HLHaixiong Liu
Haixiong Liu
WXWenjin Xu
Wenjin Xu
JFJiying Feng
Jiying Feng
HMHong Ma
Hong Ma
JZJianbin Zhang
Jianbin Zhang
WZWenhua Zhou
Wenhua Zhou
Heroin use disorder is a chronic and relapsing disease that induces persistent changes in the brain. The diagnoses of heroin use disorders are mainly based on subjective reports and no valid biomarkers available. Recent researches have revealed that circulating miRNAs are useful non-invasive biomarkers for diagnosing brain diseases such as Alzheimer's disease, multiple sclerosis, schizophrenia, and bipolar disorder. However, studies on circulating miRNAs for the diagnosis of heroin use disorders are rarely reported. In this study, we investigated the differential expression of plasma miRNAs in 57 heroin-dependent patients. Based on literature research and microarray analysis, two candidate miRNAs, miR-320a and let-7b-5p, were selected and analyzed by quantitative real-time RT-PCR. The results showed miR-320a and let-7b were significantly upregulated in plasma of the heroin-dependent patients compared to that in healthy controls. The area under curves (AUCs) of receiver operating characteristic (ROC) curves of miR-320a and let-7b-5p were 0.748 and 0.758, respectively. The sensitivities of miR-320a and let-7b-5p were 71.9 and 70.2%, while the specificities of miR-320a and let-7b-5p were 76.1 and 78.3%, respectively. The combination of these two miRNAs predicted heron dependence with an AUC of 0.782 (95% CI 0.687–0.876), with 73.7% sensitivity and 82.6% specificity. Our findings suggest a potential use for circulating miRNAs as biomarkers for the diagnosis of heroin abuse.

21 January 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
QHQingxiao Hong
Qingxiao Hong
WXWenjin Xu
Wenjin Xu
ZLZi Lin
Zi Lin
JLJing Liu
Jing Liu
WCWeisheng Chen
Weisheng Chen
HLHuifen Liu
Huifen Liu
Epigenetic modifications such as DNA methylation play important roles in regulating gene expression and may mediate neuroplasticity and lead to drug-induced aberrant behaviors. Although several brain regions and neurobiological mechanisms have been suggested to be involved in these processes, there is remarkably little known about the effects of DNA methylation on heroin-seeking behavior. Using a Sprague-Dawley rat model, we show that heroin self-administration resulted in gamma-aminobutyric acid type A receptor subunit delta (GABRD) gene hypomethylation, which was associated with transcriptional upregulation of GABRD in the nucleus accumbens (NAc). Systemic l-methionine (MET) administration significantly strengthened the reinstatement of heroin-seeking behavior induced by heroin priming, whereas intra-NAc injections of the DNA methyltransferase (DNMT) inhibitor 5-aza-2′-deoxycytidine (5-Aza-dC) had the opposite effect on heroin-seeking. Meanwhile, 5-Aza-dC treatment decreased DNA methylation and upregulated the expression of GABRD in the NAc, whereas MET had the opposite effect. Our results also reveal that 5-Aza-dC might alter the methylation landscape of the GABRD gene by directly repressing DNMT1 and DNMT3A expression. Furthermore, reinstatement of heroin-seeking behavior was significantly inhibited by directly overexpressing GABRD and remarkably reinforced by GABRD gene silencing in the NAc. Collectively, these results suggest that targeting the GABRD gene and its methylation might represent a novel pharmacological strategy for treating heroin addiction and relapse.

1 October 2018 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
XZXueyong Zhou
Xueyong Zhou
HLHang Li
Hang Li
DLDaying Liu
Daying Liu
JHJianchao Hao
Jianchao Hao
HLHuifen Liu
Huifen Liu
XLXianzhi Lu
Xianzhi Lu